Millions of women worldwide face the heartbreaking challenge of age-related infertility, and U-Ploid Biotechnologies is on a mission to transform their lives.
Co-founded by Jordan Abdi (CEO), Chloe Charalambous (COO), and Alexandre Webster (CSO), U-Ploid Biotechnologies is dedicated to significantly improving the success rates of IVF leading to a healthy pregnancy. Their approach involves the development of therapeutics designed to radically improve the quality of egg cells in older women and, in doing so, tackle age-related infertility.
Selected for the prestigious Accelerate@Babraham program, U-Ploid is "thrilled to join the vibrant BioEscalator community". The company's founders have said they are "highly impressed by the state-of-the-art facilities and resources available at BioEscalator", which will be instrumental in achieving their core milestones over the coming years. They share that "the proximity to the Wolfson Imaging Center is an added advantage for their essential super-resolution microscopy assays".
U-Ploid is eager to collaborate with other innovative companies at BioEscalator and contribute to the thriving life science ecosystem. We welcome U-Ploid to the BioEscalator community and look forward to supporting their groundbreaking work.